Year: 2026
Type: review
Abstract: Marine ecosystems have yielded a remarkable diversity of bioactive metabolites with relevance for antiviral drug discovery. This article reviews recent advances in marine-derived compounds investigated as anti-HIV agents. Metabolites, such as sulfated polysaccharides, lectins, alkaloids, and terpenoids, display inhibitory activity across multiple stages of the HIV life cycle, including viral entry, reverse transcription, integration, and maturation. From sponge-inspired development of AZT to the application of Griffithin in clinical trials for the prophylaxis of the HIV infection, recent discoveries showcase the chemical diversity of marine ecosystems and validate their utility as hit and compound sources in drug discovery. We highlight possible mechanisms of action, as well as translational hurdles from research to clinical trials. Overall, marine biodiversity represents a valuable and underexploited reservoir for the development of novel HIV therapeutics.
Source: Marine Drugs
DOI: 10.3390/md24020070
Language: English
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,499
Awards: G2578531282, G2773950190, Instituto de Ciências Moleculares, Centro de investigação interdisciplinar Egas Moniz, Centro de Química de Coimbra, Instituto de Bioengenharia e Biociências, Centro de Química de Coimbra, G6997658380, Instituto para a Saúde e a Bioeconomia, Centro de Química de Coimbra
OpenAlex ID: W7128200155
